Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;44(2):157-65.
doi: 10.1007/s12016-012-8304-4.

Imaging in psoriatic arthritis

Affiliations
Review

Imaging in psoriatic arthritis

Allen Anandarajah. Clin Rev Allergy Immunol. 2013 Apr.

Abstract

Psoriatic arthritis (PsA), a chronic inflammatory arthritis associated with psoriasis, is often associated with significant inflammation and joint damage leading to a decrease in quality of life measures. Plain radiographs have traditionally been used to detect and estimate the extent of joint damage. Newer imaging modalities such as ultrasound and MRI however, have provided the ability to detect joint damage earlier and measure the extent of joint damage more accurately, than with radiographs. These imaging modalities also provide a sensitive means of assessing for the presence of and quantifying the amount of inflammation. Furthermore, these imaging modalities can help with the identification of enthesitis, tendonitis, and dactylitis, features that can help make a diagnosis of PsA. Additionally, MRI and scintigraphy can help in the early detection and assessment of sacroiliitis and axial disease. In addition to benefits with diagnosis and prognosis, recent advances in imaging techniques have led to their increased use in the assessment of efficacy of novel therapies for psoriatic arthritis. Imaging modalities therefore allow for early detection, assessment of joint inflammation and joint damage as well as in the estimation of disease activity of PsA and thereby enable the clinician to treat PsA early, adequately, and safely.

PubMed Disclaimer

References

    1. J Rheumatol. 1997 Jun;24(6):1106-10 - PubMed
    1. Clin Exp Dermatol. 2008 Jan;33(1):70-3 - PubMed
    1. Ann Rheum Dis. 2008 Jan;67(1):26-30 - PubMed
    1. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii55-7 - PubMed
    1. J Rheumatol. 2009 Sep;36(9):1963-70 - PubMed

LinkOut - more resources